DRUG

Bright Minds Biosciences Inc. is a biotechnology company focused on developing novel drugs targeting neuropsychiatry and pain disorders. The company's drug development platform centers on selective serotonin receptor agonists designed to avoid the hallucinogenic effects of traditional psychedelics. Bright Minds is developing treatments for conditions including epilepsy, pain, depression, and other neurological and psychiatric disorders. The company employs structure-based drug design and medicinal chemistry to create differentiated therapeutic candidates. Bright Minds aims to address significant unmet medical needs in central nervous system disorders.